6533b82ffe1ef96bd1295a0d

RESEARCH PRODUCT

Benefits of tiotropium/olodaterol compared with tiotropium in patients receiving COPD LAMA at baseline: pooled analysis of 4 clinical trials

Gary T. FergusonDave SinghFlorian VoßRoland BuhlA. De La Hoz

subject

medicine.medical_specialtyCOPDbiologybusiness.industryTiotropium-olodaterolLamabiology.organism_classificationmedicine.diseaseClinical trialPooled analysisInternal medicinemedicineIn patientbusinessBaseline (configuration management)https://doi.org/10.1055/s-0039-3403211